Atlas Trials

TME Alteration in HER2 Positive Breast Cancer

Clinical trial NCT06533670 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06533670
Sponsor
Seoul National University Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast CancerHER2-positive Breast CancerChemotherapy Effect
Start date
2024-07-19
Primary completion
2026-07-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.